Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches.

Frontiers in immunology - 1 Jan 2021

Casalegno Garduño Rosaely, Däbritz Jan

Abstract excerpt

CD8+ T cells are involved in the pathogenesis of inflammatory bowel disease (IBD), a complex multifactorial chronic disease. Here, we present an overview of the current research with the controversial findings of CD8+ T cell subsets and discuss some possible perspectives on their therapeutic value in IBD. Studies on the role of CD8+ T cells in IBD have contradictory outcomes, which might be related to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colitis, Ulcerative
Share to Cytotoxicity, Immunologic
Share to Immunity, Mucosal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunologic Memory

Share to Immunotherapy

Share to Inflammation Mediators

Share to Interleukin-17

Share to Intestinal Mucosa

Source

Open in PubMed Open full text

Identifiers

PMID: 34707610
DOI: 10.3389/fimmu.2021.738762
PMCID: PMC8542854

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches.PMID 34707610Read ↗

The Th17 Cell Population and the Immune Homeostasis of the Gastrointestinal TractSemantic proximity Read ↗

Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.Semantic proximity Read ↗

Pro-inflammatory innate-like T cells are expanded in the blood and inflamed intestine in Crohn’s DiseaseSemantic proximity Read ↗

Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.Semantic proximity Read ↗

Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.Semantic proximity Read ↗

Tissue-embedded CD4⁺ plasticity defines mucosal immunity in Inflammatory Bowel DiseaseSemantic proximity Read ↗

An Overview of Tissue-Resident Memory T Cells in the Intestine: From Physiological Functions to Pathological MechanismsSemantic proximity Read ↗

Innate and adaptive immunity in inflammatory bowel disease.Semantic proximity Read ↗

CD8+ regulatory T cells-A distinct T-cell lineage or a transient T-cell phenotype?Semantic proximity Read ↗

Tissue-Resident T Cells in Chronic Relapsing-Remitting Intestinal Disorders.Semantic proximity Read ↗

Naive T cells in the gut of newly diagnosed, untreated adult patients with inflammatory bowel disease.Semantic proximity Read ↗

Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.